Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) Followed by Docetaxel Versus Oxaliplatin-Capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative Advanced Gastric Cancers. Anant Ramaswamy , Prabhat Bhargava , Biswajit Dubashi , Anuj Gupta , Akhil Kapoor , Sujay Srinivas , Omshree Shetty , Poonam Jadhav , Veena Desai , Vanita Noronha , Amit Joshi , Nandini Menon , Vijay M. Patil , Bal Krishna Mishra , Bipinesh Sansar , Arpita Singh , Swapnil Patel , Satyendra Narayan Singh , Ipsita Dhal , Kunal Ranjan Vinayak , Vikash Pal , Sarika Mandavkar , Sadhana Kannan , Deepali Chaugule , Rajshree Patil , Manali Parulekar , Chaitali Nashikkar , Suman Kumar Ankathi , Rajiv Kumar Kaushal , Aekta Shah , Prasanth Ganesan , Smita Kayal , Ramesh Ananthakrishnan , Noorzia Syed , Debdeep Samaddar , Venkatesh Kapu , Anokhi Shah , D. Kaaviya , R. Suganiya , Nirmala Devi Srinivasan , Kumar Prabhash , Vikas Ostwal JNCI CANCER SPECTRUM（2024）
AI 理解论文
溯源树
样例
